In its rush for the next breakthrough, the field of psychiatry often discards older, effective treatments due to historical stigma. For instance, MAO inhibitors and modern, safer Electroconvulsive Therapy (ECT) are highly effective for specific depression types but are underutilized because of past negative associations, a phenomenon driven more by politics than science.

The advent of SSRIs was a major innovation that moved depression treatment into primary care and reduced stigma. However, this shift had a downside: physicians became less familiar with older, more cumbersome but potent drugs like MAOIs and lithium, narrowing the therapeutic arsenal for tough cases.

Hyperactivity in certain brain circuits during manic episodes can be neurotoxic, leading to the atrophy of networks responsible for interoception (perceiving internal states). This explains why individuals may not register their own extreme symptoms like having no sleep for days or speaking excessively.

The history of depression treatment shows a recurring pattern: a new therapy (from psychoanalysis to Prozac) is overhyped as a cure-all, only for disappointment to set in as its limitations and side effects become clear. This cycle of idealization then devaluation prevents a realistic assessment of a treatment's specific uses and downsides.

During deep brain stimulation (DBS) for movement disorders, accidentally stimulating nearby brain regions can cause brief side effects like laughter or panic. Neurosurgeon Dr. Casey Halpern explains these unintended effects are not just errors, but crucial discoveries that have revealed how to therapeutically target circuits for conditions like depression and OCD.

The widespread belief that depression stems from a chemical imbalance was a successful marketing hypothesis by drug companies, not a scientifically proven fact. After 60 years of research, no consistent evidence supports the theory, yet it drove massive antidepressant adoption.

Unlike many other psychiatric conditions, the psychiatric consensus is that talk therapy by itself is rarely, if ever, sufficient for managing bipolar disorder. It must be combined with drug therapies to address the underlying neurochemical and neural circuit disruptions effectively.

A key, yet incredible, feature of a manic episode is the ability to go seven or more days with zero sleep. Critically, the individual is not troubled by this profound sleep deprivation and continues to operate with high energy, a defining symptom that distinguishes mania from other states.

A significant number of medications prescribed for mental illness are also used to treat epilepsy. This overlap suggests that mental disorders and seizure conditions share underlying biological mechanisms, opening the door for non-pharmacological epilepsy treatments like the ketogenic diet to be applied to psychiatry.